Strata Skin Sciences, Inc.
SSKN
$1.43
-$0.05-3.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.19% | 0.36% | 3.30% | 0.61% | -7.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.19% | 0.36% | 3.30% | 0.61% | -7.36% |
| Cost of Revenue | -9.94% | -7.15% | -9.35% | -2.92% | -1.57% |
| Gross Profit | -1.38% | 6.65% | 14.66% | 3.46% | -11.53% |
| SG&A Expenses | 2.52% | 12.29% | 3.85% | 0.42% | -3.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.53% | 3.12% | -2.75% | -1.94% | -3.69% |
| Operating Income | -5.30% | -20.65% | 32.48% | 15.41% | -22.03% |
| Income Before Tax | -18.91% | -38.73% | 19.06% | 6.54% | -32.16% |
| Income Tax Expenses | -84.78% | -84.78% | -84.78% | -84.78% | -246.03% |
| Earnings from Continuing Operations | -18.26% | -38.22% | 19.90% | 7.31% | -29.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.26% | -38.22% | 19.90% | 7.31% | -29.72% |
| EBIT | -5.30% | -20.65% | 32.48% | 15.41% | -22.03% |
| EBITDA | -72.32% | -1,728.75% | 138.34% | 50.72% | -297.53% |
| EPS Basic | -1.30% | -16.73% | 32.20% | 16.80% | -25.30% |
| Normalized Basic EPS | 14.45% | 5.42% | 33.76% | 12.30% | -23.61% |
| EPS Diluted | -1.30% | -16.73% | 32.20% | 16.80% | -25.30% |
| Normalized Diluted EPS | 14.45% | 5.42% | 33.76% | 12.30% | -23.61% |
| Average Basic Shares Outstanding | 16.79% | 18.20% | 13.60% | 9.00% | 4.42% |
| Average Diluted Shares Outstanding | 16.79% | 18.20% | 13.60% | 9.00% | 4.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |